African Swine Fever Virus Vaccine Compositions
Summary
The European Patent Office has published a patent application (EP2026030491A1) for African Swine Fever Virus vaccine compositions and methods of making and using them. The publication date is March 18, 2026. The inventors have not yet been designated.
What changed
The European Patent Office (EPO) has published patent application EP2026030491A1 concerning African Swine Fever Virus vaccine compositions. This application details methods for making and using these vaccine compositions. The publication date is March 18, 2026, and it is designated for various European states.
This publication represents a new patent filing and does not impose immediate compliance obligations. However, companies involved in veterinary vaccine development or manufacturing should be aware of this filing as it pertains to potential intellectual property in the field of African Swine Fever prevention. Further monitoring of the patent prosecution process is recommended to determine if a granted patent will issue.
Source document (simplified)
AFRICAN SWINE FEVER VIRUS VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
Publication EP2026030491A1 Kind: A1 Mar 18, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
A61K 39/12 20060101AFI20260207BHEP A61P 31/20 20060101ALI20260207BHEP C12N 7/04 20060101ALI20260207BHEP G01N 33/577 20060101ALI20260207BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.